Navigation Links
‘Adverse events’ eat into NZ health budgt

The consequences of healthcare going wrong is "a critical issue", consuming 30c for every $1 spent on health, according to a parliamentary select committee//.

The health committee, in its report on this year's estimates for Vote Health, called for steps to tackle the high incidence of "adverse events" and indicated exhausted doctors and nurses as one factor.

On an average, it cost $10,200, to treat a patient who suffered an unintended or negative event while in care. Such events cost the health system a total of $870 million a year.

Green MP, Sue Kedgley, the committee chairwoman said. "It's a shocking figure but what horrified me is there is no new money to do anything about it. This is a huge, preventable expense; we could do something about it."

Kedgley wanted hospitals to be open about their adverse-event rates as an incentive to reduce them. "It's not to blame and shame, but we need to put the spotlight on this area."

Adverse events include infections that develop as an aftermath of a hospital stay, allergic reactions to drugs, medication errors, heart attacks, pneumonia and blood clots after surgery.

Two-thirds of these adverse events were preventable and one-third was considered "highly preventable".

Health boards were adequately funded to address the issue and were doing so, according to Health Minister Pete Hodgson.


Page: 1

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Debate Rages over firing of HIV infected health care workers
3. Patient’s perception of health status helps in better recover
4. Antioxidants protect health tissue in people undergoing radiation therapy.
5. Sexual abuse affect health for a lifetime
6. Smoking a greater risk than HIV? Yes say health experts!!!!
7. How much can exercise improve health?
8. Bald head bad health
9. Drink grape juice for health
10. For healthy lungs
11. Borderline blood pressure- possible health risk
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: